🔗 Share this article Treasury Chief Reeves Plans Specific Action on Living Costs in Upcoming Financial Plan Treasury head Reeves has announced she is planning "targeted action to tackle household expense challenges" in next month's Budget. In comments to media outlets, she noted that reducing inflation is a shared responsibility of both the government and the Bank of England. The UK's inflation rate is expected to be the highest among the G7 advanced economies this calendar year and the following year. Possible Energy Cost Interventions Reports indicate the government could intervene to bring down energy bills, such as by reducing the present 5% level of value-added tax charged on energy supplies. An additional option is to reduce some of the policy costs currently added to household expenses. Fiscal Limitations and Expert Expectations The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will show how much scope there is for these measures. The view from the majority of experts is that the Chancellor will have to introduce tax increases or budget cuts in order to adhere to her self-imposed borrowing rules. Previously on the same day, calculations suggested there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the more modest range of projections. "It is a joint responsibility between the central bank and the government to further reduce some of the sources of price increases," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and World Bank. Revenue Commitments and International Issues While a great deal of the attention has been on probable tax increases, the chancellor said the latest information from the OBR had not altered her pledge to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance. She blamed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the fiscal revenue measures, probably to be directed on those "with the broadest shoulders." International Economic Tensions Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "Our security interests always take priority." Recent statement by Chinese authorities to tighten export controls on rare earths and other resources that are crucial for advanced tech production led American leader Donald Trump to suggest an extra 100% tariff on imports from China, increasing the risk of an all-out commercial conflict between the two global powers. The US Treasury Secretary labeled China's decision "commercial pressure" and "a international production control attempt." Questioned on accepting the US offer to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access." She said the decision was "damaging for the international commerce and causes further headwinds." "In my view there are fields where we need to challenge China, but there are also important chances to trade with China's economy, including banking sector and other areas of the economic system. We've got to maintain that balance correct." The chancellor also affirmed she was cooperating with other major economies "on our own essential resources approach, so that we are more independent." NHS Medicine Costs and Funding The Chancellor also recognized that the price the NHS spends on medicines could rise as a result of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and capital. Some of the world's largest drug companies have said in recent statements that they are either pausing or canceling projects in the UK, with several blaming the modest returns they are obtaining. Last month, the government science advisor said the price the NHS pays for medicines would need to increase to halt companies and pharmaceutical investment departing from the United Kingdom. The Chancellor stated to media: "It has been observed due to the cost structure, that medical research, innovative medicines have not been offered in the United Kingdom in the extent that they are in other continental states." "The objective is to ensure that patients receiving care from the NHS are able to receive the best critical medicines in the globe. And so we are looking at all of that, and... aiming to attract additional capital into the UK."